1. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD
- Author
-
Christophe Barba, Gianvito Caggiano, Christophe O. Soulage, Laetitia Koppe, Denis Fouque, Griet Glorieux, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Department of Emergency and Organ Transplantation, Section of Animal Production, Università degli studi di Bari Aldo Moro (UNIBA), Ghent University Hospital, Institut National de la Sante et de la Recherche Medicale (Inserm) Institut National des Sciences Appliquees de Lyon (INSA-Lyon) Fondation pour la Recherche Medicale National Operational Program FSE-ERDF Research and Innovation, Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Università degli studi di Bari Aldo Moro = University of Bari Aldo Moro (UNIBA), and ROSSI, Sabine
- Subjects
CHRONIC KIDNEY-DISEASE ,Male ,IMPACT ,Health, Toxicology and Mutagenesis ,uremic toxins ,030232 urology & nephrology ,lcsh:Medicine ,Urine ,Gut flora ,Kidney ,Toxicology ,Gastroenterology ,Feces ,Mice ,0302 clinical medicine ,RNA, Ribosomal, 16S ,Medicine and Health Sciences ,p-cresyl-sulfate ,INSULIN-RESISTANCE ,0303 health sciences ,biology ,fecal microbiota transplantation ,3. Good health ,[SDV.TOX] Life Sciences [q-bio]/Toxicology ,medicine.anatomical_structure ,[SDV.TOX]Life Sciences [q-bio]/Toxicology ,Metabolome ,medicine.symptom ,DNA, Bacterial ,medicine.medical_specialty ,P-CRESYL SULFATE ,Renal function ,Inflammation ,Article ,03 medical and health sciences ,Insulin resistance ,INFLAMMATION ,Metabolic Diseases ,Internal medicine ,Glucose Intolerance ,medicine ,Animals ,INDOXYL SULFATE ,MODULATION ,Renal Insufficiency, Chronic ,Uremia ,030304 developmental biology ,business.industry ,lcsh:R ,medicine.disease ,biology.organism_classification ,Gastrointestinal Microbiome ,Mice, Inbred C57BL ,Transplantation ,[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition ,Disease Models, Animal ,UREMIC SOLUTE ,business ,[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition ,Biomarkers ,chronic kidney disease ,Kidney disease - Abstract
International audience; Background: Chronic kidney disease (CKD) is a renal disorder characterized by the accumulation of uremic toxins with limited strategies to reduce their concentrations. A large amount of data supports the pivotal role of intestinal microbiota in CKD complications and as a major source of uremic toxins production. Here, we explored whether fecal microbiota transplantation (FMT) could be attenuated in metabolic complication and uremic toxin accumulation in mice with CKD. Methods: Kidney failure was chemically induced by a diet containing 0.25% (w/w) of adenine for four weeks. Mice were randomized into three groups: control, CKD and CKD + FMT groups. After four weeks, CKD mice underwent fecal microbiota transplantation (FMT) from healthy mice or phosphate buffered saline as control. The gut microbiota structure, uremic toxins plasmatic concentrations, and metabolic profiles were explored three weeks after transplantation. Results: Associated with the increase of alpha diversity, we observed a noticeable improvement of gut microbiota disturbance, after FMT treatment. FMT further decreased p-cresyl sulfate accumulation and improved glucose tolerance. There was no change in kidney function. Conclusions: These data indicate that FMT limited the accumulation of uremic toxins issued from intestinal cresol pathway by a beneficial effect on gut microbiota diversity. Further studies are needed to investigate the FMT efficiency, the timing and feces amount for the transplantation before, to become a therapeutic option in CKD patients.
- Published
- 2020
- Full Text
- View/download PDF